Matches in Nanopublications for { ?s ?p "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in GBC and will be a novel therapeutic target as an enhancer of sensitivity to 5-FU-based regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_assertion description "[Aberrant Nrf2 activation provoked by Keap1 alteration is one of the molecular mechanisms for chemotherapeutic resistance in GBC and will be a novel therapeutic target as an enhancer of sensitivity to 5-FU-based regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764246.RA8rpwCBbFbwrVAkhwfSy--WJ6f5ufLBcJ9LWi8ErH82g130_provenance.